NovoLog and Panitumumab Intravenous
Determining the interaction of NovoLog and Panitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: NovoLog, NovoLog FlexPen, NovoLog PenFill, Fiasp, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Novolog
Generic Name: panitumumab
Brand name: Vectibix
Synonyms: Panitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog-Panixine
- NovoLog-Panixine DisperDose
- NovoLog-Panlor
- NovoLog-Panlor Tablet
- NovoLog-Panlor Tablets
- NovoLog-Panlor-DC
- Panitumumab Intravenous-NovoLog FlexPen
- Panitumumab Intravenous-Novolog Injection
- Panitumumab Intravenous-NovoLog Mix 70/30
- Panitumumab Intravenous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Panitumumab Intravenous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Panitumumab Intravenous-NovoLog Mix 70/30 FlexPen